The global syphilis treatment market is experiencing substantial growth due to growing incidences of the disease worldwide. This trend is driven by various factors, including absence of access to healthcare, unsafe sexual practices, and limited public health interventions. The market comprises a broad range of treatments, with bacteriostatic agents